Latest Headlines

  1. FDA Clears First Flexible Shaver Technology For Interventional Gastroenterology

    Interscope, Inc. announced recently the receipt of marketing clearance from the FDA for the EndoRotor System in the USA to commercialize in gastroenterology and colorectal surgery.

  2. Medical Device Companies Cope With India's Stent Price Caps

    Medical device companies Abbott, Boston Scientific, Johnson & Johnson, and Medtronic are trying to come to grips with Indian regulators’ decision to set a price cap on cardiac stents by refiling applications to withdraw certain products, as well as lobbying against such regulation, which they contend increases the risk of introducing new products into the country and places such products out of patients’ reach.

  3. Hill-Rom Unveils Mobile, Connected Airway Clearance System For Patients On the Move

    Hill-Rom has unveiled an airway clearance system that is integrated into a mobile vest and allows patients more freedom of movement while receiving their respiratory therapies. 

  4. Teleflex’s Intra-Aortic Balloon Pump (IABP) Cleared By FDA

    Teleflex Incorporated, a leading global provider of medical technologies for critical care and surgery, has announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its AC3 Optimus Intra-Aortic Balloon Pump (IABP).

  5. Boston Scientific Looks To Keep Up Momentum, Preps Return Of Lotus TAVR Device

    Boston Scientific's chief executive says the company intends to continue its momentum achieving top-line growth across all business segments, and is preparing to re-introduce its Lotus device into the burgeoning transcatheter aortic valve replacement (TAVR) market in 2017’s fourth quarter.

  6. Could Fiber Optic Probes Replace Traditional Biopsies?

    Successfully miniaturized multimodal optical technology combines three nonlinear imaging techniques into one probe, said German scientists.

  7. Medtronic’s Resolute Onyx Drug-Eluting Stent Approved By FDA

    Medtronic plc recently announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the Resolute Onyx Drug-Eluting Stent (DES). The Resolute Onyx DES builds on the proven clinical performance and superior deliverability of the Resolute Integrity DES to further strengthen the gold standard safety and efficacy of DES technology.

  8. Baxter on “Right Path” for Top Quartile Performance, Says CEO

    Baxter topped Q1 expectations and delivered a four percent sales increase that allowed the company to raise its 2017 forecast. 

  9. Zimmer Biomet CEO Confident In Restoring Adequate Supply To Fuel 2017 Growth

    Zimmer Biomet CEO David Dvorak told investors that the company will build on gains achieved during the first quarter as the company ramps up production in its Warsaw facility, which is subject to ongoing remediation activities. 

  10. Olympus To Acquire Healthcare Systems Integrator Image Stream Medical

    On April 28, 2017, Olympus Corporation of the Americas (OCA) based in Center Valley, PA signed a definitive agreement to acquire Image Stream Medical, Inc., a healthcare systems integrator based in Littleton, MA.